MapLight Therapeutics, Inc. (MPLT)

NASDAQ: MPLT · Real-Time Price · USD

11.98

-0.20 (-1.64%)

At close: Aug 11, 2026, 4:00 PM EDT

12.00

+0.02 (0.17%)

After-hours: Aug 11, 2026, 7:54 PM EDT

MapLight Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-199.48	-161.15	-77.58
Depreciation & Amortization	0.57	0.58	0.7
Stock-Based Compensation	45.43	36.01	1.08
Other Adjustments	-1.77	-0.73	0.05
Changes in Accounts Payable	2.32	1.38	-1.35
Changes in Accrued Expenses	3.14	2.9	2.17
Changes in Other Operating Activities	-11.24	-17.12	-3.89
Operating Cash Flow	-163.77	-138.14	-78.82
Operating Cash Flow Growth	-	-	-
Capital Expenditures	-0.5	-0.47	-0.77
Purchases of Investments	-	-408.23	-125.02
Proceeds from Sale of Investments	115.03	85.5	45
Investing Cash Flow	-293.7	-323.21	-80.79
Issuance of Common Stock	0.93	276	0.29
Net Common Stock Issued (Repurchased)	0.93	276	0.29
Issuance of Preferred Stock	-	198.84	119.96
Net Preferred Stock Issued (Repurchased)	-	198.84	119.96
Other Financing Activities	-4.97	-5.02	-2.19
Financing Cash Flow	463.02	469.82	118.06
Net Cash Flow	5.55	8.48	-41.54
Free Cash Flow	-164.26	-138.61	-79.59
Free Cash Flow Growth	-	-	-
Free Cash Flow Per Share	-8.32	-15.97	-108.11
Levered Free Cash Flow	-205.18	-173.88	-80.71
Unlevered Free Cash Flow	-215.75	-181.81	-86.08

SEC Filings: 10-K · 10-Q